Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03219775 |
|---|---|
| Brief Title: | Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma (TITAN-TCC) |
| First Submitted : | July 4, 2017 |
| First Submitted that Met QC Criteria : | July 14, 2017 |
| First Posted : | July 18, 2017 |
| Last Update Submitted that Met QC Criteria : | November 2, 2021 |
| Last Update Posted : | November 3, 2021 |